Literature DB >> 15331703

Ubiquitous activation of the Nipah virus fusion protein does not require a basic amino acid at the cleavage site.

Markus Moll1, Sandra Diederich, Hans-Dieter Klenk, Markus Czub, Andrea Maisner.   

Abstract

Nipah virus (NiV), a highly pathogenic paramyxovirus, causes a systemic infection in vivo and is able to replicate in cultured cells of many species and organs. Such pantropic paramyxoviruses generally encode fusion (F) proteins with multibasic cleavage sites activated by furin or other ubiquitous intracellular host cell proteases. In contrast, NiV has an F protein with a single arginine (R109) at the cleavage site, as is the case with paramyxoviruses that are activated by trypsin-like proteases only present in specific cells or tissues and therefore only cause localized infections. Unlike these viruses, cleavage of the NiV F protein is ubiquitous and does not require the addition of exogenous proteases in cell culture. To determine the importance of the amino acid sequence at the NiV F protein cleavage site for ubiquitous activation, we generated NiV F proteins with mutations around R109. Surprisingly, neither the exchange of amino acids upstream of R109 nor replacement of the basic residue itself interfered with F cleavage. Thus, R109 is not essential for F cleavage and activation. Our data demonstrate that NiV F-protein activation depends on a novel type of proteolytic cleavage that has not yet been described for any other paramyxovirus F protein. NiV F activation is mediated by a ubiquitous protease that requires neither a monobasic nor a multibasic cleavage site and therefore differs from the furin- or trypsin-like proteases known to activate other ortho- and paramyxovirus fusion proteins. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331703      PMCID: PMC514977          DOI: 10.1128/JVI.78.18.9705-9712.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review).

Authors:  S R Durell; I Martin; J M Ruysschaert; Y Shai; R Blumenthal
Journal:  Mol Membr Biol       Date:  1997 Jul-Sep       Impact factor: 2.857

2.  A morbillivirus that caused fatal disease in horses and humans.

Authors:  K Murray; P Selleck; P Hooper; A Hyatt; A Gould; L Gleeson; H Westbury; L Hiley; L Selvey; B Rodwell
Journal:  Science       Date:  1995-04-07       Impact factor: 47.728

3.  Trypsin-resistant protease activation mutants of an influenza virus.

Authors:  M Orlich; D Linder; R Rott
Journal:  J Gen Virol       Date:  1995-03       Impact factor: 3.891

4.  Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2.

Authors:  D Ortmann; M Ohuchi; H Angliker; E Shaw; W Garten; H D Klenk
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

5.  Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus.

Authors:  M Watanabe; A Hirano; S Stenglein; J Nelson; G Thomas; T C Wong
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

Authors:  M Tashiro; Y Yokogoshi; K Tobita; J T Seto; R Rott; H Kido
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin.

Authors:  M Vey; W Schäfer; B Reis; R Ohuchi; W Britt; W Garten; H D Klenk; K Radsak
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

Review 8.  The pathogenic determinant of influenza virus.

Authors:  R Rott
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

9.  Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160.

Authors:  S Hallenberger; V Bosch; H Angliker; E Shaw; H D Klenk; W Garten
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

10.  Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease.

Authors:  A Stieneke-Gröber; M Vey; H Angliker; E Shaw; G Thomas; C Roberts; H D Klenk; W Garten
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more
  36 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  Side chain packing below the fusion peptide strongly modulates triggering of the Hendra virus F protein.

Authors:  Everett Clinton Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment.

Authors:  Sandra Diederich; Lucie Sauerhering; Michael Weis; Hermann Altmeppen; Norbert Schaschke; Thomas Reinheckel; Stephanie Erbar; Andrea Maisner
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Complete sequence of the genome of avian paramyxovirus type 2 (strain Yucaipa) and comparison with other paramyxoviruses.

Authors:  Madhuri Subbiah; Sa Xiao; Peter L Collins; Siba K Samal
Journal:  Virus Res       Date:  2008-06-20       Impact factor: 3.303

5.  Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates.

Authors:  Stéphane Biacchesi; Quynh N Pham; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.

Authors:  J Lizbeth Reyes Zamora; Victoria Ortega; Gunner P Johnston; Jenny Li; Nicole M André; I Abrrey Monreal; Erik M Contreras; Gary R Whittaker; Hector C Aguilar
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

7.  Tyrosine residues in the cytoplasmic domains affect sorting and fusion activity of the Nipah virus glycoproteins in polarized epithelial cells.

Authors:  Carolin Weise; Stephanie Erbar; Boris Lamp; Carola Vogt; Sandra Diederich; Andrea Maisner
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

8.  Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.

Authors:  Hatem A Elshabrawy; Jilao Fan; Christine S Haddad; Kiira Ratia; Christopher C Broder; Michael Caffrey; Bellur S Prabhakar
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

9.  Nipah virus infection and glycoprotein targeting in endothelial cells.

Authors:  Stephanie Erbar; Andrea Maisner
Journal:  Virol J       Date:  2010-11-08       Impact factor: 4.099

10.  Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail.

Authors:  Lena Thiel; Sandra Diederich; Stephanie Erbar; Dennis Pfaff; Hellmut G Augustin; Andrea Maisner
Journal:  Virol J       Date:  2008-12-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.